Evidence map›Paper›PMID 32154561›Full record

ArticleThe Journal of clinical endocrinology and metabolism2020

The Impact of Mild Autonomous Cortisol Secretion on Bone Turnover Markers.

Shobana Athimulam, Danae Delivanis, Melinda Thomas, William F Young, Sundeep Khosla, Matthew T Drake, Irina Bancos

2 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04860180 naunknown statusnot on this map

Effect of Surgical or Conservative Approach in Patients With Adrenal Incidentalomas on Cardiovascular, Metabolic, Neuropsychological and Bone Manifestations: Respective Roles of Cortisol Secretion and Glucocorticoid Sensitivity

TypeinterventionalSponsorFondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoRan2016 to 2022Enrolled61ConditionsAdrenal Incidentaloma, Subclinical HypercortisolismArmsadrenalectomy
NCT05255900 completednot on this mapstarted 2022, after this paper: background citation

Metabolic, Pressor and Neuropsychological Effects of Metyrapone Treatment in Patients With Hypercortisolism

TypeobservationalSponsorIstituto Auxologico ItalianoRan2022 to 2025Enrolled20ConditionsHypercortisolismArmsMetyrapone Capsules
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 34 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. An Overlooked Disease: Minimal Autonomous Cortisol Secretion (MACS). A Narrative Review.Endocrine, metabolic & immune disorders drug targets · 2024
    Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Steroid profiling in the diagnosis of mild and overt Cushing's syndrome.Best practice & research. Clinical endocrinology & metabolism · 2021
    Review
  18. Review
  19. The Impact of Mild Autonomous Cortisol Secretion on Bone Turnover Markers.The Journal of clinical endocrinology and metabolism · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Shobana AthimulamDivision of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, Minnesota.
Danae DelivanisDivision of Endocrinology, University of Patras, Rio Patras, Greece.
Melinda ThomasDivision of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, Minnesota.
William F YoungDivision of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, Minnesota.
Sundeep KhoslaDivision of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, Minnesota.
Matthew T DrakeDivision of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, Minnesota.
Irina BancosDivision of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, Minnesota.
Mayo Clinic · USUniversity of Patras · GR

Funding

Skeletal Consequences of Mild Autonomous Cortisol SecretionK23DK121888 · NIDDK · MAYO CLINIC ROCHESTER · PI BANCOS, IRINA · 2019 to 2022
$630k
NIDDK NIH HHS K23 DK121888
6 · The paper itself

Abstract

contextSeveral studies have reported increased risk of fragility fractures in patients with mild autonomous cortisol secretion (MACS), discordant to the degree of bone density deterioration.

objectiveTo evaluate the effect of MACS on bone metabolism in patients with adrenal adenomas.

designCross-sectional study with prospective enrollment, 2014-2019.

settingReferral center. PATIENTS: 213 patients with adrenal adenomas: 22 Cushing syndrome (CS), 92 MACS and 99 nonfunctioning adrenal tumors (NFAT).

main outcome measuresOsteocalcin, procollagen I intact N-terminal (PINP), C-terminal telopeptide (CTX), sclerostin.

resultsPatients with CS demonstrated lower markers of bone formation compared with patients with MACS and NFAT (CS vs MACS vs NFAT: mean osteocalcin 14.8 vs 20.1 vs 21.3 ng/mL [P < 0.0001]; mean PINP 34.8 vs 48.7 vs 48.5 µg/L [P = 0.003]). Severity of cortisol excess was inversely associated with sclerostin (CS vs MACS vs NFAT: mean sclerostin 419 vs 538 vs 624 ng/L, [P < 0.0001]). In a multivariable model of age, sex, body mass index, cortisol, and bone turnover markers, sclerostin was a significant predictor of low bone mass in patients with MACS (OR 0.63 [CI 95%, 0.40-0.98] for each 100 ng/L of sclerostin increase).After adrenalectomy, osteocalcin, CTX, and sclerostin increased by a mean difference of 6.3 ng/mL, 0.12 ng/mL, and 171 pg/mL (P = 0.02 for all), respectively.

conclusionsLower sclerostin level in patients with MACS reflects a reduction in osteocyte function or number associated with exposure to chronic cortisol excess. Increase in bone turnover markers after adrenalectomy suggests restoration of favorable bone metabolism.

Indexed as

Adaptor Proteins, Signal TransducingAdenomaAdolescentAdrenal Gland NeoplasmsAdultBiomarkersBone and BonesBone RemodelingCollagen Type ICross-Sectional StudiesCushing SyndromeFemaleHumansHydrocortisoneMaleMiddle AgedAdaptor Proteins, Signal TransducingBiomarkersCollagen Type Icollagen type I trimeric cross-linked peptideHydrocortisoneOsteocalcinPeptidesProcollagenSOST protein, humanbone turnover markersCushing syndromeMACSnonfunctioning adrenal tumorsosteopeniaosteoporosissclerostin

Identifiers

PMID32154561
PMCPMC7108681
OpenAlexW3010773902

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.